Literature DB >> 23345075

Involvement of dynorphin and kappa opioid receptor in yohimbine-induced reinstatement of heroin seeking in rats.

Yan Zhou1, Francesco Leri, Stephanie L Grella, Jane V Aldrich, Mary Jeanne Kreek.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23345075      PMCID： PMC3756541          DOI： 10.1002/syn.21638

Source DB:  PubMed          Journal:  Synapse        ISSN： 0887-4476            Impact factor:   2.562


× No keyword cloud information.
  24 in total

1.  The effects of naltrexone maintenance on the response to yohimbine in healthy volunteers.

Authors:  M I Rosen; T R Kosten; M J Kreek
Journal:  Biol Psychiatry       Date:  1999-06-15       Impact factor: 13.382

Review 2.  The reinstatement model of drug relapse: history, methodology and major findings.

Authors:  Yavin Shaham; Uri Shalev; Lin Lu; Harriet de Wit; Jane Stewart
Journal:  Psychopharmacology (Berl)       Date:  2002-10-26       Impact factor: 4.530

3.  Effect of the endogenous kappa opioid agonist dynorphin A(1-17) on cocaine-evoked increases in striatal dopamine levels and cocaine-induced place preference in C57BL/6J mice.

Authors:  Yong Zhang; Eduardo R Butelman; Stefan D Schlussman; Ann Ho; Mary Jeanne Kreek
Journal:  Psychopharmacology (Berl)       Date:  2004-01-08       Impact factor: 4.530

4.  Yohimbine-induced withdrawal and anxiety symptoms in opioid-dependent patients.

Authors:  Susan M Stine; Steven M Southwick; Ismene L Petrakis; Thomas R Kosten; Dennis S Charney; John H Krystal
Journal:  Biol Psychiatry       Date:  2002-04-15       Impact factor: 13.382

5.  Prior activation of kappa opioid receptors by U50,488 mimics repeated forced swim stress to potentiate cocaine place preference conditioning.

Authors:  Jay P McLaughlin; Benjamin B Land; Shuang Li; John E Pintar; Charles Chavkin
Journal:  Neuropsychopharmacology       Date:  2006-04       Impact factor: 7.853

6.  Neuropeptide Y (NPY) suppresses yohimbine-induced reinstatement of alcohol seeking.

Authors:  Andrea Cippitelli; Ruslan Damadzic; Anita C Hansson; Erick Singley; Wolfgang H Sommer; Robert Eskay; Annika Thorsell; Markus Heilig
Journal:  Psychopharmacology (Berl)       Date:  2009-12-10       Impact factor: 4.530

7.  Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats.

Authors:  Mark S Todtenkopf; Jacqueline F Marcus; Philip S Portoghese; William A Carlezon
Journal:  Psychopharmacology (Berl)       Date:  2004-01-16       Impact factor: 4.530

Review 8.  Peptide kappa opioid receptor ligands: potential for drug development.

Authors:  Jane V Aldrich; Jay P McLaughlin
Journal:  AAPS J       Date:  2009-05-09       Impact factor: 4.009

9.  Involvement of arginine vasopressin and V1b receptor in heroin withdrawal and heroin seeking precipitated by stress and by heroin.

Authors:  Yan Zhou; Francesco Leri; Erin Cummins; Marisa Hoeschele; Mary Jeanne Kreek
Journal:  Neuropsychopharmacology       Date:  2007-04-18       Impact factor: 7.853

10.  Stress-induced cocaine craving and hypothalamic-pituitary-adrenal responses are predictive of cocaine relapse outcomes.

Authors:  Rajita Sinha; Miguel Garcia; Prashni Paliwal; Mary Jeanne Kreek; Bruce J Rounsaville
Journal:  Arch Gen Psychiatry       Date:  2006-03
View more
  21 in total

1.  Synergistic blockade of alcohol escalation drinking in mice by a combination of novel kappa opioid receptor agonist Mesyl Salvinorin B and naltrexone.

Authors:  Yan Zhou; Rachel Saylor Crowley; Konrad Ben; Thomas E Prisinzano; Mary Jeanne Kreek
Journal:  Brain Res       Date:  2017-03-02       Impact factor: 3.252

Review 2.  Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development.

Authors:  George F Koob
Journal:  Pharmacol Rev       Date:  2021-01       Impact factor: 25.468

Review 3.  Genetics of opiate addiction.

Authors:  Brian Reed; Eduardo R Butelman; Vadim Yuferov; Matthew Randesi; Mary Jeanne Kreek
Journal:  Curr Psychiatry Rep       Date:  2014-11       Impact factor: 5.285

4.  Long-Term Reduction of Kappa Opioid Receptor Function by the Biased Ligand, Norbinaltorphimine, Requires c-Jun N-Terminal Kinase Activity and New Protein Synthesis in Peripheral Sensory Neurons.

Authors:  Raehannah J Jamshidi; Laura C Sullivan; Blaine A Jacobs; Teresa A Chavera; Kelly A Berg; William P Clarke
Journal:  J Pharmacol Exp Ther       Date:  2016-09-07       Impact factor: 4.030

5.  Incisional Injury Modulates Morphine Reward and Morphine-Primed Reinstatement: A Role of Kappa Opioid Receptor Activation.

Authors:  Chinwe A Nwaneshiudu; Xiao-You Shi; J David Clark
Journal:  Anesth Analg       Date:  2020-01       Impact factor: 5.108

Review 6.  Involvement of Activated Brain Stress Responsive Systems in Excessive and "Relapse" Alcohol Drinking in Rodent Models: Implications for Therapeutics.

Authors:  Yan Zhou; Mary Jeanne Kreek
Journal:  J Pharmacol Exp Ther       Date:  2018-04-18       Impact factor: 4.030

7.  Role of the kappa-opioid receptor system in stress-induced reinstatement of nicotine seeking in rats.

Authors:  Stephanie L Grella; Douglas Funk; Kathy Coen; Zhaoxia Li; A D Lê
Journal:  Behav Brain Res       Date:  2014-02-28       Impact factor: 3.332

8.  κ Opioid receptors in the nucleus accumbens shell mediate escalation of methamphetamine intake.

Authors:  Timothy W Whitfield; Joel E Schlosburg; Sunmee Wee; Adam Gould; Olivier George; Yanabel Grant; Eva R Zamora-Martinez; Scott Edwards; Elena Crawford; Leandro F Vendruscolo; George F Koob
Journal:  J Neurosci       Date:  2015-03-11       Impact factor: 6.167

9.  A method for conducting functional MRI studies in alert nonhuman primates: initial results with opioid agonists in male cynomolgus monkeys.

Authors:  Marc J Kaufman; Amy C Janes; Blaise deB Frederick; Melanie Brimson-Théberge; Yunjie Tong; Samuel B McWilliams; Ashley Bear; Timothy E Gillis; Katrina M Schrode; Perry F Renshaw; S Stevens Negus
Journal:  Exp Clin Psychopharmacol       Date:  2013-06-17       Impact factor: 3.157

10.  Effects of stressors on the reinforcing efficacy of nicotine in adolescent and adult rats.

Authors:  Sheng Zou; Douglas Funk; Megan J Shram; A D Lê
Journal:  Psychopharmacology (Berl)       Date:  2013-10-25       Impact factor: 4.530
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.